Psoriasis and cardiovascular risk: strength in numbers, part II. (Q36185077)

12 August 2017

Psoriasis and cardiovascular risk: strength in numbers, part II. (English)

1 reference

12 August 2017

Sinéad M Langan

3

0 references

Joel M Gelfand

object named as

Joel M Gelfand

series ordinal

1

0 references

author name string

Nehal N Mehta

series ordinal

2

1 reference

PMCID

3426317

12 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Journal of Investigative Dermatology

12 August 2017

1 reference

12 August 2017

131

1 reference

12 August 2017

1007-1010

1 reference

12 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2011.32

12 August 2017

0 references

cites work

Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Validity of The Health Improvement Network (THIN) for the study of psoriasis.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Psoriasis and cardiovascular risk: strength in numbers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

The risk of stroke in patients with psoriasis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

AJC editor's consensus: psoriasis and coronary artery disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Psoriasis and metabolic disease: epidemiology and pathophysiology

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Cause-specific excess deaths associated with underweight, overweight, and obesity

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Is an internal comparison better than using national data when estimating mortality in longitudinal studies?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

External validity of randomised controlled trials: "to whom do the results of this trial apply?".

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Threats to applicability of randomised trials: exclusions and selective participation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Reminiscences of the Veterans Administration trial of the treatment of hypertension

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426317

Uric acid and cardiovascular risk

5 December 2018

1 reference

12 December 2020

Prevalence of myocardial infarction in patients with psoriasis in central China

1 reference

12 December 2020

Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial

1 reference

12 December 2020

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

12 December 2020

Clinical severity of psoriasis in last 20 years of PUVA study

1 reference

12 December 2020

Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FJID.2011.32

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/JID.2011.32

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

3426317